Jane Street Group, LLC Meridian Bioscience Inc Call Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$19.97 - $26.94 $95,856 - $129,312	-4,800 Reduced 6.97%	64,100 $1.66 Million
Q4 2021 Feb 15, 2022	SELL	$17.46 - $21.61 $319,518 - $395,463	-18,300 Reduced 20.99%	68,900 $1.41 Million
Q3 2021 Nov 16, 2021	BUY	$17.35 - $22.5 $635,010 - $823,500	36,600 Added 72.33%	87,200 $1.68 Million
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $689,783 - $1.08 Million	38,300 Added 311.38%	50,600 $1.12 Million
Q1 2021 May 18, 2021	BUY	$19.76 - $29.89 $39,520 - $59,780	2,000 Added 19.42%	12,300 $323,000
Q4 2020 Feb 17, 2021	SELL	$15.73 - $21.66 $4,719 - $6,498	-300 Reduced 2.83%	10,300 $193,000
Q2 2020 Aug 17, 2020	BUY	$7.84 - $23.29 $83,104 - $246,874	10,600 New	10,600 $247,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.